Evidence map›Paper›PMID 30526533›Full record

Trial reportBMC cancer2018

Non-linear transformations of age at diagnosis, tumor size, and number of positive lymph nodes in prediction of clinical outcome in breast cancer.

Carina Forsare, Martin Bak, Anna-Karin Falck, Dorthe Grabau, Fredrika Killander, Per Malmström, Lisa Rydén, Olle Stål, Marie Sundqvist, Pär-Ola Bendahl and 1 more

Open access · goldAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in BMC cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Carina ForsareFaculty of Medicine, Department of Clinical Sciences Lund, Oncology and Pathology, Lund University, Medicon Village Building 404, Scheelevägen 2, SE-223 81, Lund, Sweden. carina.forsare@med.lu.se.ORCID http://orcid.org/0000-0002-2987-2940
Martin BakDepartment of Pathology, Odense University Hospital, DK-5000, Odense, Denmark.
Anna-Karin FalckDepartment of Surgery, Helsingborg Hospital, SE-281 85, Helsingborg, Sweden.
Dorthe GrabauDepartment of Pathology, Lund University, Skåne University Hospital, SE-221 85, Lund, Sweden.
Fredrika KillanderFaculty of Medicine, Department of Clinical Sciences Lund, Oncology and Pathology, Lund University, Medicon Village Building 404, Scheelevägen 2, SE-223 81, Lund, Sweden.
Per MalmströmFaculty of Medicine, Department of Clinical Sciences Lund, Oncology and Pathology, Lund University, Medicon Village Building 404, Scheelevägen 2, SE-223 81, Lund, Sweden.
Lisa RydénFaculty of Medicine, Department of Clinical Sciences Lund, Division of Surgery, Skåne University Hospital, Lund University, SE-221 85, Lund, Sweden.
Olle StålDepartment of Clinical and Experimental Medicine and Department of Oncology, Linköping University, SE-581 85, Linköping, Sweden.
Marie SundqvistDepartment of Surgery, County Hospital, SE-391 85, Kalmar, Sweden.
Pär-Ola BendahlFaculty of Medicine, Department of Clinical Sciences Lund, Oncology and Pathology, Lund University, Medicon Village Building 404, Scheelevägen 2, SE-223 81, Lund, Sweden.
Mårten FernöFaculty of Medicine, Department of Clinical Sciences Lund, Oncology and Pathology, Lund University, Medicon Village Building 404, Scheelevägen 2, SE-223 81, Lund, Sweden.
Lund University · SEHelsingborgs lasarett · SELandstinget i Kalmar län · SELinköping University · SEOdense University Hospital · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrognostic factors in breast cancer are often measured on a continuous scale, but categorized for clinical decision-making. The primary aim of this study was to evaluate if accounting for continuous non-linear effects of the three factors age at diagnosis, tumor size, and number of positive lymph nodes improves prognostication. These factors will most likely be included in the management of breast cancer patients also in the future, after an expected implementation of gene expression profiling for adjuvant treatment decision-making.

methodsFour thousand four hundred forty seven and 1132 women with primary breast cancer constituted the derivation and validation set, respectively. Potential non-linear effects on the log hazard of distant recurrences of the three factors were evaluated during 10 years of follow-up. Cox-models of successively increasing complexity: dichotomized predictors, predictors categorized into three or four groups, and predictors transformed using fractional polynomials (FPs) or restricted cubic splines (RCS), were used. Predictive performance was evaluated by Harrell's C-index.

resultsUsing FP-transformations, non-linear effects were detected for tumor size and number of positive lymph nodes in univariable analyses. For age, non-linear transformations did, however, not improve the model fit significantly compared to the linear identity transformation. As expected, the C-index increased with increasing model complexity for multivariable models including the three factors. By allowing more than one cut-point per factor, the C-index increased from 0.628 to 0.674. The additional gain, as measured by the C-index, when using FP- or RCS-transformations was modest (0.695 and 0.696, respectively). The corresponding C-indices for these four models in the validation set, based on the same transformations and parameter estimates from the derivation set, were 0.675, 0.700, 0.706, and 0.701.

conclusionsCategorization of each factor into three to four groups was found to improve prognostication compared to dichotomization. The additional gain by allowing continuous non-linear effects modeled by FPs or RCS was modest. However, the continuous nature of these transformations has the advantage of making it possible to form risk groups of any size.

Indexed as

AdultBreast NeoplasmsFemaleGene Expression ProfilingHumansLymphatic MetastasisLymph NodesMiddle AgedNeoplasm Recurrence, LocalPrognosisProportional Hazards ModelsRisk FactorsBreast cancerCategoricalContinuousFractional polynomialsPrognosticSplines

Identifiers

PMID30526533
PMCPMC6286551
OpenAlexW2904953226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.